期刊
PAIN RESEARCH & MANAGEMENT
卷 2019, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2019/6393150
关键词
-
资金
- Youth Science and Technology Talents Innovation Program of Hainan Association for Science and Technology [QCXM201703]
- Guangzhou Science and Technology Project [201607010288]
- Scientific and Technological Projects of Dongguan City [2018507150231644]
Migraine is one of the most common neurological disorders which poses significant socioeconomic burden worldwide. Neuroinflammation and oxidative stress both play important roles in the pathogenesis of migraine. Human urinary kallidinogenase (UK) is a tissue kallikrein derived from human urine. Increasing evidence suggests that UK may protect against ischemic stroke, but UK's treatment potential against migraine remains to be explored. Immortal BV-2 murine microglial cells were treated with UK (125nM, 250nM, and 500nM) and then given lipopolysaccharides (LPS, 1000ng/mL). Cell viability of BV-2cells was tested by the CCK-8 assay. Expressions of tumor necrosis factor-alpha (TNF alpha), prostaglandin E2 (PGE2), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) were examined with the ELISA method and western blot. Intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) were measured to determine oxidative stress. Our results showed that LPS administration increased the levels of proinflammatory cytokines (TNF alpha, PGE2, IL-6, and IL-1 beta) and oxidative stress (ROS and MDA) when compared with the control group and decreased significantly upon introduction with UK. Taken together, UK treatment reduced LPS-induced neuroinflammation and oxidative stress in a dose-dependent manner, which might be a potential treatment of migraine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据